Torsten Oliver Steinbrunn, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 16 | 2023 | 5096 | 1.270 |
Why?
|
Genes, ras | 4 | 2020 | 654 | 0.650 |
Why?
|
GTP Phosphohydrolases | 1 | 2020 | 507 | 0.570 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2012 | 2435 | 0.490 |
Why?
|
Electroporation | 1 | 2014 | 259 | 0.420 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2016 | 2869 | 0.420 |
Why?
|
Gene Knockdown Techniques | 6 | 2016 | 1620 | 0.350 |
Why?
|
Cell Survival | 7 | 2020 | 5764 | 0.330 |
Why?
|
MAP Kinase Signaling System | 3 | 2016 | 1481 | 0.330 |
Why?
|
Gene Transfer Techniques | 1 | 2014 | 1202 | 0.330 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1250 | 0.290 |
Why?
|
Transfection | 1 | 2014 | 5789 | 0.270 |
Why?
|
Enzyme Inhibitors | 2 | 2014 | 3699 | 0.250 |
Why?
|
RNA, Small Interfering | 5 | 2016 | 3452 | 0.240 |
Why?
|
Mutation | 8 | 2023 | 29627 | 0.240 |
Why?
|
Acetates | 1 | 2024 | 318 | 0.210 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2021 | 1641 | 0.190 |
Why?
|
ral GTP-Binding Proteins | 1 | 2020 | 9 | 0.190 |
Why?
|
ras Proteins | 2 | 2016 | 1049 | 0.170 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 823 | 0.150 |
Why?
|
Quinazolines | 1 | 2024 | 1355 | 0.150 |
Why?
|
Receptors, CXCR4 | 1 | 2021 | 730 | 0.140 |
Why?
|
Signal Transduction | 5 | 2021 | 23154 | 0.130 |
Why?
|
Myeloproliferative Disorders | 1 | 2021 | 616 | 0.120 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1598 | 0.120 |
Why?
|
Cell Line, Tumor | 5 | 2016 | 16667 | 0.120 |
Why?
|
HSP72 Heat-Shock Proteins | 1 | 2012 | 41 | 0.110 |
Why?
|
HSC70 Heat-Shock Proteins | 1 | 2012 | 55 | 0.110 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 480 | 0.100 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 799 | 0.100 |
Why?
|
Azo Compounds | 1 | 2012 | 118 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2024 | 3017 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2019 | 1075 | 0.090 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2012 | 398 | 0.090 |
Why?
|
Genes, Reporter | 1 | 2014 | 1531 | 0.090 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 883 | 0.090 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 429 | 0.090 |
Why?
|
Protein Isoforms | 1 | 2014 | 1689 | 0.080 |
Why?
|
RNA Interference | 2 | 2016 | 2845 | 0.080 |
Why?
|
Drug Combinations | 1 | 2014 | 1961 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3614 | 0.080 |
Why?
|
Gene Expression | 3 | 2016 | 7590 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2014 | 18905 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1178 | 0.070 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1351 | 0.070 |
Why?
|
Cell Death | 1 | 2012 | 1666 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2029 | 0.070 |
Why?
|
DNA Primers | 1 | 2010 | 2815 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5458 | 0.070 |
Why?
|
Genetic Testing | 1 | 2018 | 3478 | 0.060 |
Why?
|
Humans | 18 | 2024 | 746630 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8356 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2014 | 5843 | 0.060 |
Why?
|
Thalidomide | 2 | 2019 | 882 | 0.050 |
Why?
|
Germany | 1 | 2024 | 858 | 0.050 |
Why?
|
Bone Marrow | 2 | 2023 | 2902 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 1990 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9447 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10750 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 2 | 2016 | 5613 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2024 | 747 | 0.040 |
Why?
|
Coordination Complexes | 1 | 2021 | 112 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12456 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2016 | 9107 | 0.040 |
Why?
|
Peptides, Cyclic | 1 | 2021 | 394 | 0.040 |
Why?
|
Ikaros Transcription Factor | 1 | 2019 | 228 | 0.040 |
Why?
|
Ecosystem | 1 | 2021 | 475 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15386 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10311 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4622 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2023 | 1711 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1064 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 600 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2021 | 3089 | 0.030 |
Why?
|
Isoenzymes | 1 | 2016 | 1695 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2016 | 5166 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2021 | 2655 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13586 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2016 | 3602 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3268 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1854 | 0.020 |
Why?
|
Prognosis | 2 | 2023 | 29079 | 0.020 |
Why?
|
Ligands | 1 | 2016 | 3269 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2885 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3695 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3486 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2055 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 21693 | 0.020 |
Why?
|
Cell Membrane | 1 | 2016 | 3686 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 20820 | 0.020 |
Why?
|
Biopsy | 1 | 2018 | 6734 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6789 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8294 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4709 | 0.020 |
Why?
|
Protein Binding | 1 | 2016 | 9284 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8384 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 214618 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11050 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11078 | 0.010 |
Why?
|
Aged | 2 | 2024 | 164383 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19819 | 0.010 |
Why?
|
Male | 3 | 2024 | 351420 | 0.010 |
Why?
|
Adult | 2 | 2024 | 215192 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 57163 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 57586 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 86278 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 78313 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11584 | 0.010 |
Why?
|
Mice | 1 | 2021 | 80251 | 0.010 |
Why?
|
Female | 2 | 2024 | 382450 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63732 | 0.010 |
Why?
|
Animals | 1 | 2021 | 166558 | 0.010 |
Why?
|